PPARG and fatty liver disease: In the previous report, dietary β-conglycinin exhibited preventive effects of fatty liver in either the mice fed high-fat diet or the OLETF rats, which might be caused by a reduction of PPARγ2, which is one of contributors of hepatic steatosis [20, 21, 30].